Molecular signaling and translational significance of the corticotropin releasing factor system

Progress in Molecular Biology and Translational Science

Volumn 98, Issue C, 2011, Pages 235-292

  Ronan, Patrick J ^a,b,c   Summers, Cliff H ^c,d  

^a Avera Research Institute   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d W O Farber Center for Civic Leadership   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650861029     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385506-0.00006-5     Document Type: Chapter

References (444)

1. W. Vale, J. Spiess, C. Rivier, and J. Rivier Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin Science 213 4514 1981 1394 1397
2. H. Selye A syndrome produced by diverse nocuous agents Nature 138 1936 32
3. T.F. Batten, M.L. Cambre, L. Moons, and F. Vandesande Comparative distribution of neuropeptide-immunoreactive systems in the brain of the green molly, Poecilia latipinna J Comp Neurol 302 4 1990 893 919
4. S. Bhargava, and P.D. Rao Distribution of corticotropin-releasing factor immunoreactive neurons in the brain of the tigerfrog, Rana tigrina Neurosci Lett 154 12 1993 27 30
5. J.M. Mancera, A.M.D. Lopez, J.M. Perez-Figares, and P. Fernandez-Llebrez The distribution of corticotropin-releasing factorimmunoreactive neurons and nerve fibers in the brain of the snake, Natrix maura. Coexistence with arginine vasotocin and mesotocin Cell Tissue Res 264 3 1991 539 548
6. S. Yamada, and S. Mikami Immunohistochemical localization of corticotropin-releasing factor (CRF)-containing neurons in the hypothalamus of the Japanese quail, Coturnix coturnix Cell Tissue Res 239 2 1985 299 304
7. S. Mikami, and S. Yamada Immunohistochemistry of the hypothalamic neuropeptides and anterior pituitary cells in the Japanese quail J Exp Zool 232 3 1984 405 417
8. M. Sakanaka, T. Shibasaki, and K. Lederis Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex Brain Res 382 2 1986 213 238
9. R. Stolp, H.W. Steinbusch, A. Rijnberk, and R.J. Croughs Organization of ovine corticotropin-releasing factor immunoreactive neurons in the canine hypothalamo-pituitary system Neurosci Lett 74 3 1987 337 342
10. W.K. Paull, J. Scholer, A. Arimura, C.A. Meyers, J.K. Chang, and D. Chang Immunocytochemical localization of CRF in the ovine hypothalamus Peptides 3 2 1982 183 191
11. M.A. Millan, D.M. Jacobowitz, R.L. Hauger, K.J. Catt, and G. Aguilera Distribution of corticotropin-releasing factor receptors in primate brain Proc Natl Acad Sci USA 83 6 1986 1921 1925
12. J.S. Chan, C.L. Lu, N.G. Seidah, and M. Chretien Corticotropin releasing factor (CRF): effects on the release of pro- opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro Endocrinology 111 4 1982 1388 1390
13. E.B. Binder, and C.B. Nemeroff The CRF system, stress, depression and anxiety-insights from human genetic studies Mol Psychiatry 15 6 2010 574 588
14. Q.J. Pittman, and M.D. Hollenberg Urotensin I-CRF-Urocortins: a mermaid's tail Gen Comp Endocrinol 164 1 2009 7 14
15. M. Calle, G.J. Corstens, L. Wang, T. Kozicz, R.J. Denver, and H.P. Barendregt Evidence that urocortin I acts as a neurohormone to stimulate alpha MSH release in the toad Xenopus laevis Brain Res 1040 12 2005 14 28
16. L.A. Vasconcelos, C. Donaldson, L.V. Sita, C.A. Casatti, C.F. Lotfi, and L. Wang Urocortin in the central nervous system of a primate (Cebus apella): sequencing, immunohistochemical, and hybridization histochemical characterization J Comp Neurol 463 2 2003 157 175
17. H. Vaudry, J.C. Do Rego, J.C. Le Mevel, D. Chatenet, H. Tostivint, and A. Fournier Urotensin II, from fish to human Ann N Y Acad Sci 1200 2010 53 66
18. P.C. Montecucchi, and A. Henschen Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei Int J Pept Protein Res 18 2 1981 113 120
19. G.C. Boorse, and R.J. Denver Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides Gen Comp Endocrinol 146 1 2006 9 18
20. E. Potter, S. Sutton, C. Donaldson, R. Chen, M. Perrin, and K. Lewis Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary Proc Natl Acad Sci USA 91 19 1994 8777 8781
21. C.J. Donaldson, S.W. Sutton, M.H. Perrin, A.Z. Corrigan, K.A. Lewis, and J.E. Rivier Cloning and characterization of human urocortin Endocrinology 137 5 1996 2167 2170
22. K. Kageyama, M.J. Bradbury, L. Zhao, A.L. Blount, and W.W. Vale Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids Endocrinology 140 12 1999 5651 5658
23. D.P. Behan, E.B. De Souza, P.J. Lowry, E. Potter, P. Sawchenko, and W.W. Vale Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides Front Neuroendocrinol 16 4 1995 362 382
24. K.J. Catt, M.A. Millan, P.C. Wynn, F.A. Mendelsohn, and G. Aguilera Brain receptors for hypothalamic hormones Adv Biochem Psychopharmacol 43 1987 51 67
25. N. Yasuda, and M.A. Greer Distribution of corticotropin releasing factor(s) activity in neural and extraneural tissues of the rat Endocrinology 99 4 1976 944 948
26. D.T. Krieger, A. Liotta, and M.J. Brownstein Corticotropin releasing factor distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals Endocrinology 100 1 1977 227 237
27. J.A. Olschowka, T.L. O'Donohue, G.P. Mueller, and D.M. Jacobowitz The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain Peptides 3 6 1982 995 1015
28. S. Cummings, R. Elde, J. Ells, and A. Lindall Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study J Neurosci 3 7 1983 1355 1368
29. L.W. Swanson, P.E. Sawchenko, J. Rivier, and W.W. Vale Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study Neuroendocrinology 36 3 1983 165 186
30. P. James, C. Rivier, and S. Lee Presence of corticotrophin-releasing factor and/or tyrosine hydroxylase in cells of a neural brain-testicular pathway that are labelled by a transganglionic tracer J Neuroendocrinol 20 2 2008 173 181
31. 2 receptor Proc Natl Acad Sci USA 98 13 2001 7570 7575
32. S.Y. Hsu, and A.J. Hsueh Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor Nat Med 7 5 2001 605 611
33. M.L. Wong, A. al Shekhlee, P.B. Bongiorno, A. Esposito, P. Khatri, and E.M. Sternberg Localization of urocortin messenger RNA in rat brain and pituitary Mol Psychiatry 1 4 1996 307 312
34. A.Z. Weitemier, N.O. Tsivkovskaia, and A.E. Ryabinin Urocortin 1 distribution in mouse brain is strain-dependent Neuroscience 132 3 2005 729 740
35. G. Ju, and L.W. Swanson Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: I. Cytoarchitecture J Comp Neurol 280 4 1989 587 602 (Pubitemid 19069428)
36. G. Ju, and Z.S. Han Coexistence of corticotropin releasing factor and neurotensin within oval nucleus neurons in the bed nuclei of the stria terminalis in the rat Neurosci Lett 99 3 1989 246 250
37. M.M. Moga, C.B. Saper, and T.S. Gray Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat J Comp Neurol 283 3 1989 315 332
38. D.C. Choi, A.R. Furay, N.K. Evanson, M.M. Ostrander, Y.M. Ulrich-Lai, and J.P. Herman Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs J Neurosci 27 8 2007 2025 2034
39. M. Sakanaka, T. Shibasaki, and K. Lederis Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method J Comp Neurol 260 2 1987 256 298
40. 1 receptor mRNA expression J Neurosci 15 10 1995 6340 6350
41. E.A. Rybnikova, M. Pelto-Huikko, V.V. Rakitskaya, and V.G. Shalyapina Localization of corticoliberin receptors in the rat brain Neurosci Behav Physiol 33 4 2003 399 404
42. J.P. Herman, and W.E. Cullinan Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis Trends Neurosci 20 2 1997 78 84
43. D.C. Choi, N.K. Evanson, A.R. Furay, Y.M. Ulrich-Lai, M.M. Ostrander, and J.P. Herman The anteroventral bed nucleus of the stria terminalis differentially regulates hypothalamic-pituitary-adrenocortical axis responses to acute and chronic stress Endocrinology 149 2 2008 818 826
44. L.L. Sahuque, E.F. Kullberg, A.J. McGeehan, J.R. Kinder, M.P. Hicks, and M.G. Blanton Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes Psychopharmacology (Berl) 186 1 2006 122 132
45. J.C. Bittencourt, J. Vaughan, C. Arias, R.A. Rissman, W.W. Vale, and P.E. Sawchenko Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors J Comp Neurol 415 3 1999 285 312
46. A.E. Ryabinin, N.O. Tsivkovskaia, and S.A. Ryabinin Urocortin 1-containing neurons in the human Edinger-Westphal nucleus Neuroscience 134 4 2005 1317 1323
47. W.K. Paull, C.F. Phelix, M. Copeland, P. Palmiter, F.P. Gibbs, and C. Middleton Immunohistochemical localization of corticotropin releasing factor (CRF) in the hypothalamus of the squirrel monkey, Saimiri sciureus Peptides 5 Suppl 1 1984 45 51
48. T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, and C.A. Arias Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors Proc Natl Acad Sci USA 98 5 2001 2843 2848
49. K. Hashimoto, M. Nishiyama, Y. Tanaka, T. Noguchi, K. Asaba, and P.N. Hossein Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system Peptides 25 10 2004 1711 1721
50. M. Kovacs, I. Lengvari, Z. Liposits, S. Vigh, A.V. Schally, and B. Flerko Corticotropin-releasing factor (CRF)-immunoreactive neurons in the mammillary body of the rat Cell Tissue Res 240 2 1985 455 460
51. R. Bock Neuroanatomical studies on corticotropin releasing factor (CRF) Naunyn Schmiedebergs Arch Pharmacol 297 Suppl. 1 1977 S57 S58
52. M.C. Tonon, A. Burlet, M. Lauber, P. Cuet, S. Jegou, and L. Gouteux Immunohistochemical localization and radioimmunoassay of corticotropin-releasing factor in the forebrain and hypophysis of the frog Rana ridibunda Neuroendocrinology 40 2 1985 109 119
53. M. Olivereau, F. Vandesande, E. Boucique, F. Ollevier, and J.M. Olivereau Immunocytochemical localization and spatial relation to the adenohypophysis of a somatostatin-like and a corticotropin-releasing factor-like peptide in the brain of four amphibian species Cell Tissue Res 247 2 1987 317 324
54. Y. Chen, R.A. Bender, M. Frotscher, and T.Z. Baram Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis J Neurosci 21 18 2001 7171 7181
55. K.G. Commons, K.R. Connolley, and R.J. Valentino A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders Neuropsychopharmacology 28 2 2003 206 215
56. R. Jozsa, S. Vigh, B. Mess, and A.V. Schally Ontogenetic development of corticotropin-releasing factor (CRF)-containing neural elements in the brain of the chicken during incubation and after hatching Cell Tissue Res 244 3 1986 681 685
57. R.L. Hauger, D.E. Grigoriadis, M.F. Dallman, P.M. Plotsky, W.W. Vale, and F.M. Dautzenberg International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands Pharmacol Rev 55 1 2003 21 26
58. M. Arai, I.Q. Assil, and A.B. Abou-Samra Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis Endocrinology 142 1 2001 446 454
59. M.H. Perrin, and W.W. Vale Corticotropin releasing factor receptors and their ligand family Ann N Y Acad Sci 885 1999 312 328
60. E.W. Hillhouse, and D.K. Grammatopoulos The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology Endocr Rev 27 3 2006 260 286
61. 2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues Endocrinology 136 9 1995 4139 4142
62. 1 receptor in CRF signaling Acta Biochim Pol 57 1 2010 1 13
63. N. Hiroi, M.L. Wong, J. Licinio, C. Park, M. Young, and P.W. Gold Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls Mol Psychiatry 6 5 2001 540 546
64. S. Pohl, M.G. Darlison, W.C. Clarke, K. Lederis, and D. Richter Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish Eur J Pharmacol 430 23 2001 193 202
65. J.C. Cardoso, D.M. Power, G. Elgar, and M.S. Clark Isolation and characterisation of the corticotropin releasing factor receptor 1 (CRFR1) gene in a teleost fish, Fugu rubripes DNA Seq 14 3 2003 215 218 (Pubitemid 36874835)
66. F.M. Dautzenberg, K. Dietrich, M.R. Palchaudhuri, and J. Spiess Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor J Neurochem 69 4 1997 1640 1649
67. J. Yu, L.Y. Xie, and A.B. Abou-Samra Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I Endocrinology 137 1 1996 192 197
68. N. Vita, P. Laurent, S. Lefort, P. Chalon, J.M. Lelias, and M. Kaghad Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors FEBS Lett 335 1 1993 1 5
69. C.P. Chang, R.V. Pearse, S. O'Connell, and M.G. Rosenfeld Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain Neuron 11 6 1993 1187 1195
70. M.H. Perrin, C.J. Donaldson, R. Chen, K.A. Lewis, and W.W. Vale Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor Endocrinology 133 6 1993 3058 3061
71. 1 ) and a carboxyl-terminal variant Mol Cell Endocrinol 144 12 1998 21 35
72. M.R. Palchaudhuri, S. Wille, G. Mevenkamp, J. Spiess, E. Fuchs, and F.M. Dautzenberg Corticotropin-releasing factor receptor type 1 from Tupaia belangericloning, functional expression and tissue distribution Eur J Biochem 258 1 1998 78 84
73. R. Chen, K.A. Lewis, M.H. Perrin, and W.W. Vale Expression cloning of a human corticotropin-releasing-factor receptor Proc Natl Acad Sci USA 90 19 1993 8967 8971
74. T. Kishimoto, R.V. Pearse, C.R. Lin, and M.G. Rosenfeld A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle Proc Natl Acad Sci USA 92 4 1995 1108 1112
75. M. Perrin, C. Donaldson, R. Chen, A. Blount, T. Berggren, and L. Bilezikjian Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart Proc Natl Acad Sci USA 92 7 1995 2969 2973
76. P. Stenzel, R. Kesterson, W. Yeung, R.D. Cone, M.B. Rittenberg, and M.P. Stenzel-Poore Identification of a novel murine receptor for corticotropin- releasing hormone expressed in the heart Mol Endocrinol 9 5 1995 637 645
77. M.R. Palchaudhuri, R.L. Hauger, S. Wille, and E. Fuchs Dautzenberg section. Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri J Neuroendocrinol 11 6 1999 419 428
78. C.W. Liaw, T.W. Lovenberg, G. Barry, T. Oltersdorf, D.E. Grigoriadis, and E.B. De Souza Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid Endocrinology 137 1 1996 72 77
79. 2 receptor for corticotropin-releasing factor Biochim Biophys Acta 1352 2 1997 129 132
80. 2 gamma receptor Mol Endocrinol 12 8 1998 1077 1085
81. E. Potter, D.P. Behan, W.H. Fischer, E.A. Linton, P.J. Lowry, and W.W. Vale Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins Nature 349 6308 1991 423 426
82. A.F. Seasholtz, R.A. Valverde, and R.J. Denver Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals J Endocrinol 175 1 2002 89 97
83. M.O. Huising, and G. Flik The remarkable conservation of corticotropin-releasing hormone (CRH)-binding protein in the honeybee (Apis mellifera) dates the CRH system to a common ancestor of insects and vertebrates Endocrinology 146 5 2005 2165 2170
84. E. Potter, D.P. Behan, E.A. Linton, P.J. Lowry, P.E. Sawchenko, and W.W. Vale The central distribution of a corticotropin-releasing factor (CRF)- binding protein predicts multiple sites and modes of interaction with CRF Proc Natl Acad Sci USA 89 9 1992 4192 4196
85. N. Vitoratos, D.C. Papatheodorou, S.N. Kalantaridou, and G. Mastorakos "Reproductive" corticotropin-releasing hormone Ann N Y Acad Sci 1092 2006 310 318
86. D.P. Behan, D. Maciejewski, D. Chalmers, and E.B. De Souza Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells Brain Res 698 12 1995 259 264
87. 1 receptor desensitization Biochem Biophys Res Commun 298 3 2002 303 308
88. T.A. Kohout, and R.J. Lefkowitz Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization Mol Pharmacol 63 1 2003 9 18
89. C. Krasel, M. Bunemann, K. Lorenz, and M.J. Lohse Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation J Biol Chem 280 10 2005 9528 9535
90. C.A. Moore, S.K. Milano, and J.L. Benovic Regulation of receptor trafficking by GRKs and arrestins Annu Rev Physiol 69 2007 451 482
91. E. Kelly, C.P. Bailey, and G. Henderson Agonist-selective mechanisms of GPCR desensitization Br J Pharmacol 153 Suppl. 1 2008 S379 S388
92. 1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses Am J Physiol Regul Integr Comp Physiol 293 1 2007 R209 R222
93. D. Markovic, A. Punn, H. Lehnert, and D.K. Grammatopoulos Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades Mol Endocrinol 22 3 2008 689 706
94. F.M. Dautzenberg, and R.L. Hauger The CRF peptide family and their receptors: yet more partners discovered Trends Pharmacol Sci 23 2 2002 71 77
95. R.L. Hauger, V. Risbrough, O. Brauns, and F.M. Dautzenberg Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets CNS Neurol Disord Drug Targets 5 4 2006 453 479
96. R.L. Hauger, V. Risbrough, R.H. Oakley, J.A. Olivares-Reyes, and F.M. Dautzenberg Role of CRF receptor signaling in stress vulnerability, anxiety, and depression Ann N Y Acad Sci 1179 2009 120 143
97. D.K. Grammatopoulos, Y. Dai, H.S. Randeva, M.A. Levine, E. Karteris, and A.J. Easton A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes Mol Endocrinol 13 12 1999 2189 2202
98. H. Sheng, T. Sun, B. Cong, P. He, Y. Zhang, and J. Yan Corticotropin-releasing hormone stimulates SGK-1 kinase expression in cultured hippocampal neurons via CRH-R1 Am J Physiol Endocrinol Metab 295 4 2008 E938 E946
99. N. Fazal, A. Slominski, M.A. Choudhry, E.T. Wei, and M.M. Sayeed Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells FEBS Lett 435 23 1998 187 190
100. B. Wiesner, B. Roloff, K. Fechner, and A. Slominski Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy J Cell Sci 116 Pt 7 2003 1261 1268
101. A. Pisarchik, and A. Slominski Molecular and functional characterization of novel CRFR1 isoforms from the skin Eur J Biochem 271 13 2004 2821 2830
102. B. Zbytek, L.M. Pfeffer, and A.T. Slominski Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes J Endocrinol 181 3 2004 R1 R7
103. B. Zbytek, M. Pikula, R.M. Slominski, A. Mysliwski, E. Wei, and J. Wortsman Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes Br J Dermatol 152 3 2005 474 480 (Pubitemid 40547121)
104. B. Zbytek, and A.T. Slominski Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis J Cell Physiol 203 1 2005 118 126
105. A. Slominski, B. Zbytek, M. Zmijewski, R.M. Slominski, S. Kauser, and J. Wortsman Corticotropin releasing hormone and the skin Front Biosci 11 2006 2230 2248
106. 1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations J Cell Physiol 218 3 2009 593 602
107. M.A. Zmijewski, and A.T. Slominski Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20emerging role of soluble isoforms J Physiol Pharmacol 60 Suppl 4 2009 39 46
108. P.J. Peeters, F.L. Fierens, I. van den Wyngaert, H.W. Goehlmann, S.M. Swagemakers, and S.U. Kass Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice Brain Res Mol Brain Res 129 12 2004 135 150
109. N. Bayatti, and C. Behl The neuroprotective actions of corticotropin releasing hormone Ageing Res Rev 4 2 2005 258 270
110. N. Bayatti, H. Hermann, B. Lutz, and C. Behl Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system Endocrinology 146 3 2005 1205 1213
111. S. Traver, M. Marien, E. Martin, E.C. Hirsch, and P.P. Michel The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway Mol Pharmacol 70 1 2006 30 40
112. E. Arzt, and F. Holsboer CRF signaling: molecular specificity for drug targeting in the CNS Trends Pharmacol Sci 27 10 2006 531 538
113. S. Salim, B. Hite, and D.C. Eikenburg Activation of the CRF(1) receptor causes ERK1/2 mediated increase in GRK3 expression in CATH.a cells FEBS Lett 581 17 2007 3204 3210
114. M.B. McQueen, B. Devlin, S.V. Faraone, V.L. Nimgaonkar, P. Sklar, and J.W. Smoller Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q Am J Hum Genet 77 4 2005 582 595
115. R. Segurado, S.D. Detera-Wadleigh, D.F. Levinson, C.M. Lewis, M. Gill, and J.I. Nurnberger Jr. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder Am J Hum Genet 73 1 2003 49 62 (Pubitemid 36793779)
116. J. Liu, S.H. Juo, A. Dewan, A. Grunn, X. Tong, and M. Brito Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12 Mol Psychiatry 8 3 2003 333 342
117. B. Marcheco-Teruel, T.J. Flint, F.P. Wikman, M. Torralbas, L. Gonzalez, and L. Blanco A genome-wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of Cuba Am J Med Genet B Neuropsychiatr Genet 141B 8 2006 833 843
118. J.R. Kelsoe, M.A. Spence, E. Loetscher, M. Foguet, A.D. Sadovnick, and R.A. Remick A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22 Proc Natl Acad Sci USA 98 2 2001 585 590
119. A.H. Fanous, M.C. Neale, B.T. Webb, R.E. Straub, F.A. O'Neill, and D. Walsh Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families Biol Psychiatry 64 2 2008 121 127
120. N.J. Camp, M.R. Lowry, R.L. Richards, A.M. Plenk, C. Carter, and C.H. Hensel Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders Am J Med Genet B Neuropsychiatr Genet 135B 1 2005 85 93
121. G.L. Hanna, J. Veenstra-Vanderweele, N.J. Cox, M. Van Etten, D.J. Fischer, and J.A. Himle Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder Biol Psychiatry 62 8 2007 856 862
122. R. Rosmond, M. Chagnon, C. Bouchard, and P. Bjorntorp A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene-gene interaction Metabolism 50 9 2001 1059 1062
123. B.R. Mueller, and T.L. Bale Sex-specific programming of offspring emotionality after stress early in pregnancy J Neurosci 28 36 2008 9055 9065
124. M. Szyf Early life, the epigenome and human health Acta Paediatr 98 7 2009 1082 1084
125. C.S. Barr, R.L. Dvoskin, Q. Yuan, R.H. Lipsky, M. Gupte, and X. Hu CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques Arch Gen Psychiatry 65 8 2008 934 944
126. M. Tochigi, C. Kato, T. Otowa, H. Hibino, T. Marui, and T. Ohtani Association between corticotropin-releasing hormone receptor 2 (CRHR2) gene polymorphism and personality traits Psychiatry Clin Neurosci 60 4 2006 524 526 (Pubitemid 44060813)
127. E.B. Binder, D. Salyakina, P. Lichtner, G.M. Wochnik, M. Ising, and B. Putz Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment Nat Genet 36 12 2004 1319 1325
128. J. Gu, L. Sadler, S. Daiger, D. Wells, and M. Wagner Dinucleotide repeat polymorphism at the CRH gene Hum Mol Genet 2 1 1993 85
129. J.W. Smoller, J.F. Rosenbaum, J. Biederman, J. Kennedy, D. Dai, and S.R. Racette Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition Biol Psychiatry 54 12 2003 1376 1381
130. J.W. Smoller, L.H. Yamaki, J.A. Fagerness, J. Biederman, S. Racette, and N.M. Laird The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder Biol Psychiatry 57 12 2005 1485 1492
131. M.E. Keck, N. Kern, A. Erhardt, P.G. Unschuld, M. Ising, and D. Salyakina Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder Am J Med Genet B Neuropsychiatr Genet 147B 7 2008 1196 1204
132. M.A. Enoch, P.H. Shen, F. Ducci, Q. Yuan, J. Liu, and K.V. White Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP PLoS ONE 3 10 2008 e3620
133. Z. Liu, F. Zhu, G. Wang, Z. Xiao, H. Wang, and J. Tang Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression Neurosci Lett 404 3 2006 358 362
134. D. Wasserman, M. Sokolowski, V. Rozanov, and J. Wasserman The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress Genes Brain Behav 7 1 2008 14 19
135. V. De Luca, S. Tharmalingam, and J.L. Kennedy Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder Eur Psychiatry 22 5 2007 282 287 (Pubitemid 47088197)
136. R.G. Bradley, E.B. Binder, M.P. Epstein, Y. Tang, H.P. Nair, and W. Liu Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene Arch Gen Psychiatry 65 2 2008 190 200
137. S. Papiol, B. Arias, C. Gasto, B. Gutierrez, R. Catalan, and L. Fananas Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment J Affect Disord 104 13 2007 83 90
138. J. Licinio, F. O'Kirwan, K. Irizarry, B. Merriman, S. Thakur, and R. Jepson Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans Mol Psychiatry 9 12 2004 1075 1082
139. Z. Liu, F. Zhu, G. Wang, Z. Xiao, J. Tang, and W. Liu Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders Neurosci Lett 414 2 2007 155 158
140. K.J. Ressler, B. Bradley, K.B. Mercer, T.C. Deveau, A.K. Smith, and C.F. Gillespie Polymorphisms in CRHR1 and the serotonin transporter loci: gene × gene × environment interactions on depressive symptoms Am J Med Genet B Neuropsychiatr Genet 153B 3 2010 812 824
141. E.B. Binder, M.J. Owens, W. Liu, T.C. Deveau, A.J. Rush, and M.H. Trivedi Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response Arch Gen Psychiatry 67 4 2010 369 379
142. S. Tharmalingam, N. King, L.V. De, C. Rothe, D. Koszycki, and J. Bradwejn Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder Psychiatr Genet 16 3 2006 93 97
143. S.M. Villafuerte, J. Del Favero, R. Adolfsson, D. Souery, I. Massat, and J. Mendlewicz Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression Am J Med Genet 114 2 2002 222 226
144. F. Van Den Eede, T. Venken, J. Del Favero, K.F. Norrback, D. Souery, and L.G. Nilsson Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder Psychiatry Res 153 1 2007 17 25 (Pubitemid 47374829)
145. 1 Pharmacol Biochem Behav 93 3 2009 230 236
146. D. Blomeyer, J. Treutlein, G. Esser, M.H. Schmidt, G. Schumann, and M. Laucht Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use Biol Psychiatry 63 2 2008 146 151
147. B. Schmid, D. Blomeyer, J. Treutlein, U.S. Zimmermann, A.F. Buchmann, and M.H. Schmidt Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds Int J Neuropsychopharmacol 13 6 2010 703 714
148. T.S. Jones, S.C. Kaste, W. Liu, C. Cheng, W. Yang, and K.G. Tantisira CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia J Clin Oncol 26 18 2008 3031 3037
149. S. Rivest, and C. Rivier Stress and interleukin-1 beta-induced activation
150. T. Imaki, X.Q. Wang, T. Shibasaki, S. Harada, N. Chikada, and C. Takahashi Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN) Brain Res Mol Brain Res 32 2 1995 261 270
151. S. Rivest, N. Laflamme, and R.E. Nappi Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus J Neurosci 15 4 1995 2680 2695
152. J.G. Mercer, C.B. Lawrence, and T. Atkinson Hypothalamic NPY and CRF gene expression in the food-deprived Syrian hamster Physiol Behav 60 1 1996 121 127
153. L.Y. Zhong, Z.Y. Shen, and D.F. Cai Effect of three kinds (tonifying kidney, invigorating spleen, promoting blood circulation) recipes on the hypothalamus-pituitary- adrenal-thymus (HPAT) axis and CRF gene expression Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 17 1 1997 39 41
154. L. Garcia-Garcia, V. Llewellyn-Jones, I. Fernandez Fernandez, J.A. Fuentes, and J. Manzanares Acute and repeated ECS treatment increases CRF, POMC and PENK gene expression in selected regions of the rat hypothalamus NeuroReport 9 1 1998 73 77
155. N.J. Bernier, X. Lin, and R.E. Peter Differential expression of corticotropin-releasing factor (CRF) and urotensin I precursor genes, and evidence of CRF gene expression regulated by cortisol in goldfish brain Gen Comp Endocrinol 116 3 1999 461 477
156. S. Konishi, Y. Kasagi, H. Katsumata, S. Minami, and T. Imaki Regulation of corticotropin-releasing factor (CRF) type-1 receptor gene expression by CRF in the hypothalamus Endocr J 50 1 2003 21 36 (Pubitemid 36305844)
157. R.J. Herringa, S.A. Nanda, D.T. Hsu, P.H. Roseboom, and N.H. Kalin The effects of acute stress on the regulation of central and basolateral amygdala CRF-binding protein gene expression Brain Res Mol Brain Res 131 12 2004 17 25
158. C. Porcher, V. Sinniger, A. Juhem, P. Mouchet, and B. Bonaz Neuronal activity and CRF receptor gene transcription in the brains of rats with colitis Am J Physiol Gastrointest Liver Physiol 287 4 2004 G803 G814
159. V. Sinniger, C. Porcher, P. Mouchet, A. Juhem, and B. Bonaz c-fos and CRF receptor gene transcription in the brain of acetic acid-induced somato-visceral pain in rats Pain 110 3 2004 738 750
160. Y. Yamano, M. Yoshioka, Y. Toda, Y. Oshida, S. Chaki, and K. Hamamoto Regulation of CRF, POMC and MC4R gene expression after electrical foot shock stress in the rat amygdala and hypothalamus J Vet Med Sci 66 11 2004 1323 1327
161. D. Funk, Z. Li, and A.D. Le Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking Neuroscience 138 1 2006 235 243
162. P.H. Roseboom, S.A. Nanda, V.P. Bakshi, A. Trentani, S.M. Newman, and N.H. Kalin Predator threat induces behavioral inhibition, pituitary-adrenal activation and changes in amygdala CRF-binding protein gene expression Psychoneuroendocrinology 32 1 2007 44 55
163. J.M. Deussing, C. Kuhne, B. Putz, M. Panhuysen, J. Breu, and M.P. Stenzel-Poore Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity J Cereb Blood Flow Metab 27 8 2007 1476 1495
164. A. Schierloh, J. Deussing, W. Wurst, W. Zieglgansberger, and G. Rammes Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity Neurosci Lett 416 1 2007 82 86
165. T. Sherrin, T. Blank, R. Saravana, M. Rayner, J. Spiess, and C. Todorovic Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning Neuroscience 162 1 2009 14 22
166. A. Pisarchik, and A.T. Slominski Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression FASEB J 15 14 2001 2754 2756
167. Y. Kasagi, N. Horiba, K. Sakai, Y. Fukuda, and T. Suda Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells J Neuroendocrinol 14 7 2002 587 592
168. Z. Li, S.S. Kang, S. Lee, and C. Rivier Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression Mol Cell Neurosci 29 3 2005 345 354
169. R. Winsky-Sommerer, A. Yamanaka, S. Diano, E. Borok, A.J. Roberts, and T. Sakurai Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response J Neurosci 24 50 2004 11439 11448
170. T.J. Sajdyk, S.D. Fitz, and A. Shekhar The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat Stress 9 1 2006 21 28
171. A.J. Dunn, and A.H. Swiergiel The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems Eur J Pharmacol 583 23 2008 186 193
172. R.J. Valentino, and E. Van Bockstaele Convergent regulation of locus coeruleus activity as an adaptive response to stress Eur J Pharmacol 583 23 2008 194 203
173. U. Ungerstedt Stereotaxic mapping of the monoamine pathways in the rat brain Acta Physiol Scand Suppl 367 1971 1 48
174. R. Grzanna, and J.M. Fritschy Efferent projections of different subpopulations of central noradrenaline neurons Prog Brain Res 88 1991 89 101
175. K. Pacak, M. Palkovits, R. Kvetnansky, G. Yadid, I.J. Kopin, and D.S. Goldstein Effects of various stressors on in vivo norepinephrine release in the hypothalamic paraventricular nucleus and on the pituitary-adrenocortical axis Ann N Y Acad Sci 771 1995 115 130
176. A.J. Dunn, A.H. Swiergiel, and V. Palamarchouk Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress Ann N Y Acad Sci 1018 2004 25 34
177. E.J. Van Bockstaele, B.A. Reyes, and R.J. Valentino The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse Brain Res 1314 2010 162 174
178. S.M. Koegler-Muly, M.J. Owens, G.N. Ervin, C.D. Kilts, and C.B. Nemeroff Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus J Neuroendocrinol 5 1 1993 95 98
179. E.J. Van Bockstaele, E.E. Colago, and R.J. Valentino Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response J Neuroendocrinol 10 10 1998 743 757
180. E.J. Van Bockstaele, J. Chan, and V.M. Pickel Input from central nucleus of the amygdala efferents to pericoerulear dendrites, some of which contain tyrosine hydroxylase immunoreactivity J Neurosci Res 45 3 1996 289 302
181. E.J. Van Bockstaele, J. Peoples, and R.J. Valentino A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents Biol Psychiatry 46 10 1999 1352 1363
182. S.I. Tjoumakaris, C. Rudoy, J. Peoples, R.J. Valentino, and E.J. Van Bockstaele Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum J Comp Neurol 466 4 2003 445 456
183. M.L. Rouzade-Dominguez, A.L. Curtis, and R.J. Valentino Role of Barrington's nucleus in the activation of rat locus coeruleus neurons by colonic distension Brain Res 917 2 2001 206 218
184. S. Bouret, A. Duvel, S. Onat, and S.J. Sara Phasic activation of locus ceruleus neurons by the central nucleus of the amygdala J Neurosci 23 8 2003 3491 3497
185. R.J. Valentino, M.E. Page, and A.L. Curtis Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor Brain Res 555 1 1991 25 34
186. A.L. Curtis, G. Drolet, and R.J. Valentino Hemodynamic stress activates locus coeruleus neurons of unanesthetized rats Brain Res Bull 31 6 1993 737 744
187. N. Shimizu, H. Nakane, T. Hori, and Y. Hayashi CRF receptor antagonist attenuates stress-induced noradrenaline release in the medial prefrontal cortex of rats Brain Res 654 1 1994 145 148
188. G.N. Smagin, J. Zhou, R.B. Harris, and D.H. Ryan CRF receptor antagonist attenuates immobilization stress-induced norepinephrine release in the prefrontal cortex in rats Brain Res Bull 42 6 1997 431 434
189. J.M. Finlay, and M.J. Zigmond The effects of stress on central dopaminergic neurons: possible clinical implications Neurochem Res 22 11 1997 1387 1394
190. E.K. Murphy, A.F. Sved, and J.M. Finlay Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in prefrontal cortex of control or chronically stressed rats Neuroscience 116 4 2003 1081 1087
191. P.B. Chappell, M.A. Smith, C.D. Kilts, G. Bissette, J. Ritchie, and C. Anderson Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress J Neurosci 6 10 1986 2908 2914
192. B.A. Reyes, R.J. Valentino, and E.J. Van Bockstaele Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons Endocrinology 149 1 2008 122 130
193. M.E. Page, C.W. Berridge, S.L. Foote, and R.J. Valentino Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress Neurosci Lett 164 12 1993 81 84
194. A.L. Curtis, N.T. Bello, and R.J. Valentino Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination J Neurosci 21 13 2001 RC152
195. R.J. Valentino, S.L. Foote, and G. Aston-Jones Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus Brain Res 270 2 1983 363 367
196. M.K. Borsody, and J.M. Weiss Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons Brain Res 724 2 1996 149 168
197. H. Emoto, M. Tanaka, C. Koga, H. Yokoo, A. Tsuda, and M. Yoshida Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain Pharmacol Biochem Behav 45 2 1993 419 422
198. A.J. Dunn, and C.W. Berridge Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems Pharmacol Biochem Behav 27 4 1987 685 691
199. J. Lavicky, and A.J. Dunn Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis J Neurochem 60 2 1993 602 612
200. G.N. Smagin, A.H. Swiergiel, and A.J. Dunn Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex Brain Res Bull 36 1 1995 71 76
201. E.H. Lee, S.Y. Chang, and A.Y. Chen CRF facilitates NE release from the hippocampus: a microdialysis study Neurosci Res 19 3 1994 327 330
202. C. Schulz, and H. Lehnert Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study Neuroendocrinology 63 5 1996 454 458
203. A.L. Curtis, D.E. Grigoriadis, M.E. Page, J. Rivier, and R.J. Valentino Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies J Pharmacol Exp Ther 268 1 1994 359 365
204. C.A. Lowry, P.L. Johnson, A. Hay-Schmidt, J. Mikkelsen, and A. Shekhar Modulation of anxiety circuits by serotonergic systems Stress 8 4 2005 233 246
205. C.A. Lowry, M.W. Hale, A.K. Evans, J. Heerkens, D.R. Staub, and P.J. Gasser Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus Ann N Y Acad Sci 1148 2008 86 94
206. R.J. Valentino, I. Lucki, and E. Van Bockstaele Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction Brain Res 1314 2010 29 37
207. D.A. Ruggiero, M.D. Underwood, P.M. Rice, J.J. Mann, and V. Arango Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications Neuroscience 91 4 1999 1343 1354
208. L. Arborelius, M.J. Owens, P.M. Plotsky, and C.B. Nemeroff The role of corticotropin-releasing factor in depression and anxiety disorders J Endocrinol 160 1 1999 1 12
209. J. Lukkes, S. Vuong, J. Scholl, H. Oliver, and G. Forster Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation J Neurosci 29 32 2009 9955 9960
210. A.C. Magalhaes, K.D. Holmes, L.B. Dale, L. Comps-Agrar, D. Lee, and P.N. Yadav CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling Nat Neurosci 13 5 2010 622 629
211. C.A. Lowry, J.E. Rodda, S.L. Lightman, and C.D. Ingram Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system J Neurosci 20 20 2000 7728 7736
212. L.G. Kirby, K.C. Rice, and R.J. Valentino Effects of corticotropin- releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus Neuropsychopharmacology 22 2 2000 148 162
213. C.A. Lowry Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis J Neuroendocrinol 14 11 2002 911 923
214. C.H. Summers, J.L. Kampshoff, P.J. Ronan, C.A. Lowry, A.A. Prestbo, and W.J. Korzan Monoaminergic activity in subregions of raphe nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor J Neuroendocrinol 15 12 2003 1122 1133
215. E.C. Azmitia, and M. Segal An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat J Comp Neurol 179 3 1978 641 667
216. M.C. Austin, J.L. Rhodes, and D.A. Lewis Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem Neuropsychopharmacology 17 5 1997 326 341
217. T. Petrov, T.L. Krukoff, and J.H. Jhamandas Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat Cell Tissue Res 277 2 1994 289 295
218. E.B. De Souza, T.R. Insel, M.H. Perrin, J. Rivier, W.W. Vale, and M.J. Kuhar Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study J Neurosci 5 12 1985 3189 3203
219. J.C. Bittencourt, and P.E. Sawchenko Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system J Neurosci 20 3 2000 1142 1156
220. K. Van Pett, V. Viau, J.C. Bittencourt, R.K. Chan, H.Y. Li, and C. Arias Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse J Comp Neurol 428 2 2000 191 212
221. Y. Chen, K.L. Brunson, M.B. Muller, W. Cariaga, and T.Z. Baram Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus J Comp Neurol 420 3 2000 305 323
222. H.E. Day, B.N. Greenwood, S.E. Hammack, L.R. Watkins, M. Fleshner, and S.F. Maier Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus J Comp Neurol 474 3 2004 364 378
223. M.M. Lim, H.P. Nair, and L.J. Young Species and sex differences in brain distribution of corticotropin-releasing factor receptor subtypes 1 and 2 in monogamous and promiscuous vole species J Comp Neurol 487 1 2005 75 92
224. A. Korosi, J.G. Veening, T. Kozicz, M. Henckens, J. Dederen, and L. Groenink Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain Brain Res 1072 1 2006 46 54
225. 2 ) receptors in the regulation of subpopulations of serotonergic neurons Brain Res 1070 1 2006 77 89
226. M.L. Price, A.L. Curtis, L.G. Kirby, R.J. Valentino, and I. Lucki Effects of corticotropin-releasing factor on brain serotonergic activity Neuropsychopharmacology 18 6 1998 492 502
227. J.L. Lukkes, C.H. Summers, J.L. Scholl, K.J. Renner, and G.L. Forster Early life social isolation alters corticotropin-releasing factor responses in adult rats Neuroscience 158 2 2009 845 855
228. L.G. Kirby, E. Freeman-Daniels, J.C. Lemos, J.D. Nunan, C. Lamy, and A. Akanwa Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons J Neurosci 28 48 2008 12927 12937
229. J. Li, H. Takeda, M. Tsuji, L. Liu, and T. Matsumiya Antagonism of central CRF systems mediates stress-induced changes in noradrenaline and serotonin turnover in rat brain regions Methods Find Exp Clin Pharmacol 20 5 1998 409 417
230. T.W. Lovenberg, C.W. Liaw, D.E. Grigoriadis, W. Clevenger, D.T. Chalmers, and E.B. De Souza Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain Proc Natl Acad Sci USA 92 3 1995 836 840
231. R.W. Fuller The involvement of serotonin in regulation of pituitary-adrenocortical function Front Neuroendocrinol 13 3 1992 250 270
232. F. Chaouloff Physiopharmacological interactions between stress hormones and central serotonergic systems Brain Res Rev 18 1 1993 1 32
233. C.A. Lowry, M.W. Hale, A. Plant, R.J. Windle, N. Shanks, and S.A. Wood Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats Stress 12 3 2009 225 239
234. C.A. Lowry, M.W. Hale, K.A. Burke, K.J. Renner, and F.L. Moore Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa Horm Behav 56 1 2009 177 184
235. Z. Liposits, C. Phelix, and W.K. Paull Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study Histochemistry 86 6 1987 541 549
236. S.L. Petersen, R.D. Hartman, and C.A. Barraclough An analysis of serotonin secretion in hypothalamic regions based on 5-hydroxytryptophan accumulation or push-pull perfusion. Effects of mesencephalic raphe or locus coeruleus stimulation and correlated changes in plasma luteinizing hormone Brain Res 495 1 1989 9 19
237. S. Feldman, M.E. Newman, E. Gur, and J. Weidenfeld Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses NeuroReport 9 9 1998 2007 2009
238. S. Feldman, and J. Weidenfeld The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41 Brain Res Bull 45 4 1998 389 393
239. M.H. Fernstrom, M.S. Massoudi, and J.D. Fernstrom Effect of 8-hydroxy-2-(di-n-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain Life Sci 47 4 1990 283 289
240. R. Invernizzi, M. Carli, A. Di Clemente, and R. Samanin Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity J Neurochem 56 1 1991 243 247
241. M.J. Owens, E. Edwards, and C.B. Nemeroff Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin- releasing factor containing neurons in the rat brain Eur J Pharmacol 190 12 1990 113 122
242. D. Rodaros, D.A. Caruana, S. Amir, and J. Stewart Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area Neuroscience 150 1 2007 8 13
243. T.M. Korotkova, R.E. Brown, O.A. Sergeeva, A.A. Ponomarenko, and H.L. Haas Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat Eur J Neurosci 23 10 2006 2677 2685
244. P. Tagliaferro, and M. Morales Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic J Comp Neurol 506 4 2008 616 626
245. B. Wang, Y. Shaham, D. Zitzman, S. Azari, R.A. Wise, and Z.B. You Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking J Neurosci 25 22 2005 5389 5396
246. P. Tagliaferro Corticotropin releasing factor receptor 1 (CRF-R1) in the ventral tegmental area is preferentially encoded and translated by dopaminergic neurons Soc Neurosci Abstr 916 9 2007 JJ25
247. M.A. Ungless, V. Singh, T.L. Crowder, R. Yaka, D. Ron, and A. Bonci Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons Neuron 39 3 2003 401 407
248. B. Wang, Z.B. You, K.C. Rice, and R.A. Wise Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat Psychopharmacology (Berl) 193 2 2007 283 294
249. H.L. Wang, and M. Morales Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons J Comp Neurol 509 3 2008 302 318
250. P.W. Kalivas, P. Duffy, and L.G. Latimer Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat J Pharmacol Exp Ther 242 3 1987 757 763
251. M.J. Beckstead, S.C. Gantz, C.P. Ford, M.P. Stenzel-Poore, P.E. Phillips, and G.P. Mark CRF enhancement of GIRK channel-mediated transmission in dopamine neurons Neuropsychopharmacology 34 8 2009 1926 1935
252. M.R. Holahan, N.H. Kalin, and A.E. Kelley Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity Psychopharmacology (Berl) 130 2 1997 189 196
253. S. Pecina, J. Schulkin, and K.C. Berridge Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress? BMC Biol 4 2006 8
254. R.A. Wise The role of reward pathways in the development of drug dependence Pharmacol Ther 35 12 1987 227 263
255. D.J. Lodge, and A.A. Grace CRF-1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity 2004 Society For Neuroscience Washington DC Program No. 855.14(2004 Abstact Viewer/Itinerary Planner)
256. L. Lu, Z. Liu, M. Huang, and Z. Zhang Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes J Neurochem 84 6 2003 1378 1386
257. G.R. Valdez CRF receptors as a potential target in the development of novel pharmacotherapies for depression Curr Pharm Des 15 14 2009 1587 1594
258. R. Galard, R. Catalan, J.M. Castellanos, and J.M. Gallart Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test Biol Psychiatry 51 6 2002 463 468
259. C.B. Nemeroff, E. Widerlov, G. Bissette, H. Walleus, I. Karlsson, and K. Eklund Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients Science 226 4680 1984 1342 1344
260. C.M. Banki, G. Bissette, M. Arato, L. O'Connor, and C.B. Nemeroff CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia Am J Psychiatry 144 7 1987 873 877
261. K.M. Hartline, M.J. Owens, and C.B. Nemeroff Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans Ann N Y Acad Sci 780 1996 96 105
262. F.C. Raadsheer, F.J. Tilders, and D.F. Swaab Similar age related increase of vasopressin colocalization in paraventricular corticotropin-releasing hormone neurons in controls and Alzheimer patients J Neuroendocrinol 6 2 1994 131 133
263. M.C. Austin, J.E. Janosky, and H.A. Murphy Increased corticotropin- releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men Mol Psychiatry 8 3 2003 324 332
264. G. Bissette, V. Klimek, J. Pan, C. Stockmeier, and G. Ordway Elevated concentrations of CRF in the locus coeruleus of depressed subjects Neuropsychopharmacology 28 7 2003 1328 1335
265. Z. Merali, P. Kent, L. Du, P. Hrdina, M. Palkovits, and G. Faludi Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects Biol Psychiatry 59 7 2006 594 602
266. C.B. Nemeroff, M.J. Owens, G. Bissette, A.C. Andorn, and M. Stanley Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims Arch Gen Psychiatry 45 6 1988 577 579
267. Z. Merali, L. Du, P. Hrdina, M. Palkovits, G. Faludi, and M.O. Poulter Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region J Neurosci 24 6 2004 1478 1485
268. R.J. Herringa, P.H. Roseboom, and N.H. Kalin Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects Neuropsychopharmacology 31 8 2006 1822 1831
269. C.B. Nemeroff, G. Bissette, H. Akil, and M. Fink Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin Br J Psychiatry 158 1991 59 63
270. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 5 2000 477 501
271. M.D. De Bellis, P.W. Gold, T.D. Geracioti Jr., S.J. Listwak, and M.A. Kling Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression Am J Psychiatry 150 4 1993 656 657
272. R.C. Veith, N. Lewis, J.I. Langohr, M.M. Murburg, E.A. Ashleigh, and S. Castillo Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects Psychiatry Res 46 1 1993 1 8
273. I. Heuser, G. Bissette, M. Dettling, U. Schweiger, U. Gotthardt, and J. Schmider Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment Depress Anxiety 8 2 1998 71 79
274. C.M. Banki, L. Karmacsi, G. Bissette, and C.B. Nemeroff CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse Eur Neuropsychopharmacol 2 2 1992 107 113
275. R.M. Sapolsky Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 57 10 2000 925 935
276. M.E. Keck Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety Amino Acids 31 3 2006 241 250
277. G.W. Smith, J.M. Aubry, F. Dellu, A. Contarino, L.M. Bilezikjian, and L.H. Gold Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development Neuron 20 6 1998 1093 1102
278. P. Timpl, R. Spanagel, I. Sillaber, A. Kresse, J.M. Reul, and G.K. Stalla Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1110ee comments] Nat Genet 19 2 1998 162 166
279. A. Contarino, F. Dellu, G.F. Koob, G.W. Smith, K.F. Lee, and W. Vale Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1 Brain Res 835 1 1999 1 9
280. D.M. Nielsen, G.J. Carey, and L.H. Gold Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice Eur J Pharmacol 499 12 2004 135 146
281. 1 receptor antagonist, R278995/CRA0450 Eur J Pharmacol 485 13 2004 145 158
282. M. Yamano, H. Yuki, S. Yasuda, and K. Miyata Corticotropin-releasing hormone receptors mediate consensus interferon- alpha YM643-induced depression-like behavior in mice J Pharmacol Exp Ther 292 1 2000 181 187
283. E.M. Jutkiewicz, S.K. Wood, H. Houshyar, L.W. Hsin, K.C. Rice, and J.H. Woods The effects of CRF antagonists, antalarmin, CP154, 526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats Psychopharmacology (Berl) 180 2 2005 215 223
284. E.L. Webster, D.B. Lewis, D.J. Torpy, E.K. Zachman, K.C. Rice, and G.P. Chrousos In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation Endocrinology 137 12 1996 5747 5750
285. G. Griebel, J. Simiand, R. Steinberg, M. Jung, D. Gully, and P. Roger 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4- methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders J Pharmacol Exp Ther 301 1 2002 333 345
286. D.H. Overstreet, E. Friedman, A.A. Mathe, and G. Yadid The Flinders sensitive line rat: a selectively bred putative animal model of depression Neurosci Biobehav Rev 29 45 2005 739 759
287. T.L. Bale, and W.W. Vale Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses J Neurosci 23 12 2003 5295 5301
288. M. Tanaka, and G. Telegdy Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice Brain Res Bull 75 5 2008 509 512
289. A. Chen, E. Zorrilla, S. Smith, D. Rousso, C. Levy, and J. Vaughan Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior J Neurosci 26 20 2006 5500 5510
290. S.E. Hammack, M.J. Schmid, M.L. LoPresti, A. Der-Avakian, M.A. Pellymounter, and A.C. Foster Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress J Neurosci 23 3 2003 1019 1025
291. A.W. Zobel, T. Nickel, H.E. Kunzel, N. Ackl, A. Sonntag, and M. Ising Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated J Psychiatr Res 34 3 2000 171 181
292. K. Held, H. Kunzel, M. Ising, D.A. Schmid, A. Zobel, and H. Murck Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression J Psychiatr Res 38 2 2004 129 136
293. 1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response Neuropsychopharmacology 32 9 2007 1941 1949
294. D. Refojo, and F. Holsboer CRH signaling. Molecular specificity for drug targeting in the CNS Ann N Y Acad Sci 1179 2009 106 119
295. O. Bonne, C. Grillon, M. Vythilingam, A. Neumeister, and D.S. Charney Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy Neurosci Biobehav Rev 28 1 2004 65 94
296. E.D. Leonardo, and R. Hen Genetics of affective and anxiety disorders Annu Rev Psychol 57 2006 117 137
297. K.T. Britton, G. Lee, W. Vale, J. Rivier, and G.F. Koob Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat Brain Res 369 12 1986 303 306
298. M.P. Stenzel-Poore, S.C. Heinrichs, S. Rivest, G.F. Koob, and W.W. Vale Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior J Neurosci 14 5 Pt 1 1994 2579 2584
299. R.E. Carpenter, M.J. Watt, G.L. Forster, O. Overli, C. Bockholt, and K.J. Renner Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity Horm Behav 52 5 2007 600 611
300. E.P. Zorrilla, and G.F. Koob The therapeutic potential of CRF(1) antagonists for anxiety Expert Opin Investig Drugs 13 7 2004 799 828
301. F. Holsboer, and M. Ising Central CRH system in depression and anxietyevidence from clinical studies with CRH1 receptor antagonists Eur J Pharmacol 583 23 2008 350 357
302. M.B. Muller, S. Zimmermann, I. Sillaber, T.P. Hagemeyer, J.M. Deussing, and P. Timpl Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress Nat Neurosci 6 10 2003 1100 1107
303. N.K. Nguyen, M.E. Keck, A. Hetzenauer, C.K. Thoeringer, W. Wurst, and J.M. Deussing Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge Psychopharmacology (Berl) 188 3 2006 374 385
304. T.L. Bale, and W.W. Vale CRF and CRF receptors: role in stress responsivity and other behaviors Annu Rev Pharmacol Toxicol 44 2004 525 557
305. S.C. Heinrichs, and G.F. Koob Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation J Pharmacol Exp Ther 311 2 2004 427 440
306. S.C. Coste, S.E. Murray, and M.P. Stenzel-Poore Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress(1) Peptides 22 5 2001 733 741
307. V.B. Risbrough, R.L. Hauger, M.A. Pelleymounter, and M.A. Geyer Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice Psychopharmacology (Berl) 170 2 2003 178 187
308. 2 exert both additive and opposing influences on defensive startle behavior J Neurosci 24 29 2004 6545 6552
309. 2 receptors are required for potentiated startle to contextual but not discrete cues Neuropsychopharmacology 34 6 2009 1494 1503
310. P.J. Ronan, and C.H. Summers Biology, animal models G. Reyes, J.D. Elhai, J.D. Ford, Encyclopedia of Psychological Trauma 2008 Wiley Hoboken, New Jersey 80 83
311. T. Hikichi, J. Akiyoshi, Y. Yamamoto, T. Tsutsumi, K. Isogawa, and H. Nagayama Suppression of conditioned fear by administration of CRF receptor antagonist CP-154, 526 Pharmacopsychiatry 33 5 2000 189 193
312. J.H. Kehne, S. Coverdale, T.C. McCloskey, D.C. Hoffman, and J.V. Cassella Effects of the CRF(1) receptor antagonist, CP 154, 526, in the separation-induced vocalization anxiolytic test in rat pups Neuropharmacology 39 8 2000 1357 1367
313. 1 receptor Brain Res 1234 2008 59 65
314. D.L. Walker, L.A. Miles, and M. Davis Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses Prog Neuropsychopharmacol Biol Psychiatry 33 8 2009 1291 1308
315. 1 ) receptor antagonists J Med Chem 52 14 2009 4173 4191
316. 1 ) receptor antagonists J Med Chem 52 14 2009 4161 4172
317. 1 ) antagonist Pharmacol Biochem Behav 88 4 2008 497 510
318. 1 ) antagonists J Med Chem 52 9 2009 3084 3092
319. 1 ) antagonists J Med Chem 52 9 2009 3073 3083
320. Y. Lee, S. Fitz, P.L. Johnson, and A. Shekhar Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety Neuropsychopharmacology 33 2008 2586 2594
321. M.E. Keck, and F. Holsboer Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders Peptides 22 5 2001 835 844
322. 1 -R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior PLoS ONE 4 12 2009 e8528
323. G. Liebsch, R. Landgraf, M. Engelmann, P. Lorscher, and F. Holsboer Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain J Psychiatr Res 33 2 1999 153 163
324. 1 receptors in the amygdala Mol Pain 3 2007 13
325. 2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior J Neurosci 28 15 2008 3861 3876
326. M.B. Muller, and F. Holsboer Mice with mutations in the HPA-system as models for symptoms of depression Biol Psychiatry 59 12 2006 1104 1115
327. Y. Zhao, G.R. Valdez, E.M. Fekete, J.E. Rivier, W.W. Vale, and K.C. Rice Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats J Pharmacol Exp Ther 323 3 2007 846 854
328. B.B. Land, M.R. Bruchas, J.C. Lemos, M. Xu, E.J. Melief, and C. Chavkin The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system J Neurosci 28 2 2008 407 414
329. S.F. Maier, and L.R. Watkins Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor Neurosci Biobehav Rev 29 45 2005 829 841
330. C. Todorovic, J. Radulovic, O. Jahn, M. Radulovic, T. Sherrin, and C. Hippel Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety Eur J Neurosci 25 11 2007 3385 3397
331. J.M. Deussing, J. Breu, C. Kuhne, M. Kallnik, M. Bunck, and L. Glasl Urocortin 3 modulates social discrimination abilities via corticotropin- releasing hormone receptor type 2 J Neurosci 30 27 2010 9103 9116
332. 1 receptors in basolateral amygdala J Neurosci 27 39 2007 10568 10577
333. C.M. Banki, L. Karmacsi, G. Bissette, and C.B. Nemeroff Cerebrospinal fluid neuropeptides in mood disorder and dementia J Affect Disord 25 1 1992 39 45
334. J. Jolkkonen, U. Lepola, G. Bissette, C. Nemeroff, and P. Riekkinen CSF corticotropin-releasing factor is not affected in panic disorder Biol Psychiatry 33 2 1993 136 138
335. M.D. Fossey, R.B. Lydiard, J.C. Ballenger, M.T. Laraia, G. Bissette, and C.B. Nemeroff Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects Biol Psychiatry 39 8 1996 703 707 (Pubitemid 26157605)
336. B. Adinoff, R. Anton, M. Linnoila, A. Guidotti, C.B. Nemeroff, and G. Bissette Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence Neuropsychopharmacology 15 3 1996 288 295
337. R.J. Hawley, C.B. Nemeroff, G. Bissette, A. Guidotti, R. Rawlings, and M. Linnoila Neurochemical correlates of sympathetic activation during severe alcohol withdrawal Alcohol Clin Exp Res 18 6 1994 1312 1316
338. A. Erhardt, M. Ising, P.G. Unschuld, N. Kern, S. Lucae, and B. Putz Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder Neuropsychopharmacology 31 11 2006 2515 2522
339. W. Schreiber, C.J. Lauer, K. Krumrey, F. Holsboer, and J.C. Krieg Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder Neuropsychopharmacology 15 1 1996 7 15
340. V. Coric, H.H. Feldman, D.A. Oren, A. Shekhar, J. Pultz, and R.C. Dockens Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder Depress Anxiety 27 5 2010 417 425
341. C.S. de Kloet, E. Vermetten, E. Geuze, A. Kavelaars, C.J. Heijnen, and H.G.M. Westenberg Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review J Psychiatr Res 40 2006 550 567
342. C.S. de Kloet, E. Vermetten, E. Geuze, E.G. Lentjes, C.J. Heijnen, and G.K. Stalla Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder Prog Brain Res 167 2008 287 291
343. A.M. Hull Neuroimaging findings in post-traumatic stress disorder. Systematic review Br J Psychiatry 181 2002 102 110
344. H.C. Pape, and D. Pare Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear Physiol Rev 90 2 2010 419 463
345. R.W. Butler, D.L. Braff, J.L. Rausch, M.A. Jenkins, J. Sprock, and M.A. Geyer Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD Am J Psychiatry 147 10 1990 1308 1312
346. C. Grillon, and J. Baas A review of the modulation of the startle reflex by affective states and its application in psychiatry Clin Neurophysiol 114 9 2003 1557 1579
347. N.R. Swerdlow, M.A. Geyer, W.W. Vale, and G.F. Koob Corticotropin- releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide Psychopharmacology (Berl) 88 2 1986 147 152
348. K.C. Liang, K.R. Melia, M.J. Miserendino, W.A. Falls, S. Campeau, and M. Davis Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex J Neurosci 12 6 1992 2303 2312
349. G.H. Pelton, Y. Lee, and M. Davis Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex Brain Res 778 2 1997 381 387
350. J. Radulovic, A. Ruhmann, T. Liepold, and J. Spiess Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2 J Neurosci 19 12 1999 5016 5025
351. M.W. Pitts, C. Todorovic, T. Blank, and L.K. Takahashi The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory J Neurosci 29 22 2009 7379 7388
352. Y. Ohmura, T. Izumi, T. Yamaguchi, I. Tsutsui-Kimura, T. Yoshida, and M. Yoshioka The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor Neuropsychopharmacology 35 6 2010 1271 1278
353. P.J. Ronan, G.L. Kramer, M.L. Kram, and F. Petty CRF in the learned helplessness animal model of depression Soc Neurosci Abstr 26 2000 2266
354. S.E. Hammack, K.J. Richey, M.J. Schmid, M.L. LoPresti, L.R. Watkins, and S.F. Maier The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress J Neurosci 22 3 2002 1020 1026
355. R. Adamec, D. Fougere, and V. Risbrough CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD Int J Neuropsychopharmacol 13 6 2010 747 757
356. National Center for Post-Traumatic Stress Disorder DoVA PTSD and Problems with Alcohol Use http://www.samhsa.gov/csatdisasterrecovery/outreach/ ptsdAndProblemsWithAlcohol.pdf
357. D. Kozaric-Kovacic, T. Ljubin, and M. Grappe Comorbidity of posttraumatic stress disorder and alcohol dependence in displaced persons Croat Med J 41 2 2000 173 178
358. R.M. Richter, E.P. Zorrilla, A.M. Basso, G.F. Koob, and F. Weiss Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study Alcohol Clin Exp Res 24 12 2000 1765 1772
359. Z. Sarnyai, Y. Shaham, and S.C. Heinrichs The role of corticotropin-releasing factor in drug addiction Pharmacol Rev 53 2 2001 209 243
360. R.A. Wise, and M. Morales A ventral tegmental CRF-glutamate-dopamine interaction in addiction Brain Res 1314 2009 38 43
361. N.E. Goeders, and G.F. Guerin Effects of the CRH receptor antagonist CP-154, 526 on intravenous cocaine self-administration in rats Neuropsychopharmacology 23 5 2000 577 586
362. L. Lu, D. Liu, and X. Ceng Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats Eur J Pharmacol 415 23 2001 203 208
363. C.K. Funk, and G.F. Koob A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats Brain Res 1155 2007 172 178
364. D.J. Macey, G.F. Koob, and A. Markou CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist Brain Res 866 12 2000 82 91
365. Z. Sarnyai, J. Hohn, G. Szabo, and B. Penke Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats Life Sci 51 26 1992 2019 2024
366. C. Rivier, and W. Vale Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism Brain Res 422 2 1987 403 406
367. Z. Sarnyai, E. Biro, B. Penke, and G. Telegdy The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats Brain Res 589 1 1992 154 156
368. R.M. Richter, and F. Weiss In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats Synapse 32 4 1999 254 261
369. P.E. Merlo, M. Lorang, M. Yeganeh, dF. Rodriguez, J. Raber, and G.F. Koob Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis J Neurosci 15 8 1995 5439 5447
370. dF. Rodriguez, M.R. Carrera, M. Navarro, G.F. Koob, and F. Weiss Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal Science 276 5321 1997 2050 2054
371. L.B. Callahan, K.E. Tschetter, and P.J. Ronan Binge cocaine use and withdrawal sensitizes brain reward systems to stress/arousal: a possible mechanism driving relapse Soc Neurosci Abstr 2008 online(479.9/QQ45)
372. A.C. DeVries, and A. Pert Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor Psychopharmacology (Berl) 137 4 1998 333 340 (Pubitemid 28305368)
373. A.C. DeVries, S.E. Taymans, J.M. Sundstrom, and A. Pert Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by corticotropin-releasing factor Brain Res 786 12 1998 39 46
374. S. Erb, Y. Shaham, and J. Stewart Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period Psychopharmacology (Berl) 128 4 1996 408 412
375. S.H. Ahmed, and G.F. Koob Cocaine- but not food-seeking behavior is reinstated by stress after extinction Psychopharmacology (Berl) 132 3 1997 289 295
376. J.R. Mantsch, and N.E. Goeders Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine Psychopharmacology (Berl) 142 4 1999 399 407
377. Y. Shaham, S. Erb, and J. Stewart Stress-induced relapse to heroin and cocaine seeking in rats: a review Brain Res Brain Res Rev 33 1 2000 13 33
378. S. Erb, Y. Shaham, and J. Stewart The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats J Neurosci 18 14 1998 5529 5536
379. Y. Shaham, S. Erb, S. Leung, Y. Buczek, and J. Stewart CP-154, 526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats Psychopharmacology (Berl) 137 2 1998 184 190
380. L. Lu, X. Ceng, and M. Huang Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats NeuroReport 11 11 2000 2373 2378
381. S. Erb, N. Salmaso, D. Rodaros, and J. Stewart A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats Psychopharmacology (Berl) 158 4 2001 360 365
382. S. Erb, and J. Stewart A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking J Neurosci 19 20 1999 RC35
383. S. Erb, D. Funk, and A.D. Le Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin- releasing factor (CRF) in rats Psychopharmacology (Berl) 170 4 2003 383 389
384. S. Erb, D. Funk, and A.D. Le Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity Neurosci Lett 383 3 2005 209 214
385. 1 receptors J Neurophysiol 97 1 2007 937 941
386. M.F. Olive, H.N. Koenig, M.A. Nannini, and C.W. Hodge Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake Pharmacol Biochem Behav 72 12 2002 213 220
387. H.A. Baldwin, S. Rassnick, J. Rivier, G.F. Koob, and K.T. Britton CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat Psychopharmacology (Berl) 103 2 1991 227 232
388. S. Rassnick, S.C. Heinrichs, K.T. Britton, and G.F. Koob Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal Brain Res 605 1 1993 25 32
389. C.K. Funk, E.P. Zorrilla, M.J. Lee, K.C. Rice, and G.F. Koob Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats Biol Psychiatry 61 1 2007 78 86
390. M. Roberto, M.T. Cruz, N.W. Gilpin, V. Sabino, P. Schweitzer, and M. Bajo Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence Biol Psychiatry 67 9 2010 831 839
391. D.R. Sparta, A.M. Sparrow, E.G. Lowery, J.R. Fee, D.J. Knapp, and T.E. Thiele Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures Alcohol Clin Exp Res 32 2 2008 259 265
392. E.G. Lowery, M. Spanos, M. Navarro, A.M. Lyons, C.W. Hodge, and T.E. Thiele CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6 J mice independent of the HPA axis Neuropsychopharmacology 35 6 2010 1241 1252
393. E.G. Lowery, and T.E. Thiele Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism CNS Neurol Disord Drug Targets 9 1 2010 77 86
394. E.G. Lowery, A.M. Sparrow, G.R. Breese, D.J. Knapp, and T.E. Thiele The CRF-1 receptor antagonist, CP-154, 526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice Alcohol Clin Exp Res 32 2 2008 240 248
395. W. Vale, C. Rivier, M.R. Brown, J. Spiess, G. Koob, and L. Swanson Chemical and biological characterization of corticotropin releasing factor Recent Prog Horm Res 39 1983 245 270
396. S. Kauser, A. Slominski, E.T. Wei, and D.J. Tobin Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides FASEB J 20 7 2006 882 895
397. E.P. Zorrilla, Y. Tache, and G.F. Koob Nibbling at CRF receptor control of feeding and gastrocolonic motility Trends Pharmacol Sci 24 8 2003 421 427
398. N.R. Swerdlow, and G.F. Koob Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat Pharmacol Biochem Behav 23 2 1985 303 307
399. C.A. Lowry, P. Deviche, and F.L. Moore Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion Brain Res 513 1 1990 94 100
400. L.K. Takahashi Role of CRF(1) and CRF(2) receptors in fear and anxiety Neurosci Biobehav Rev 25 78 2001 627 636
401. G.F. Koob, and E.P. Zorrilla Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor Curr Opin Investig Drugs 11 1 2010 63 71
402. C.B. Nemeroff The role of corticotropin-releasing factor in the pathogenesis of major depression Pharmacopsychiatry 21 2 1988 76 82
403. L. Yang, X. Tang, L.L. Wellman, X. Liu, and L.D. Sanford Corticotropin releasing factor (CRF) modulates fear-induced alterations in sleep in mice Brain Res 1276 2009 112 122
404. A. Slominski, A. Pisarchik, D.J. Tobin, J.E. Mazurkiewicz, and J. Wortsman Differential expression of a cutaneous corticotropin-releasing hormone system Endocrinology 145 2 2004 941 950
405. 2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay Neuropharmacology 38 3 1999 441 448
406. S.V. Wu, P.Q. Yuan, L. Wang, Y.L. Peng, C.Y. Chen, and Y. Tache Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus Endocrinology 148 4 2007 1675 1687
407. R.E. Carpenter, W.J. Korzan, C. Bockholt, M.J. Watt, G.L. Forster, and K.J. Renner Corticotropin releasing factor influences aggression and monoamines: modulation of attacks and retreats Neuroscience 158 2 2009 412 425
408. J.L. Lukkes, G.L. Forster, K.J. Renner, and C.H. Summers Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens Eur J Pharmacol 578 23 2008 185 193
409. 1 receptor antagonists as antidepressants and anxiolytics: progress to date CNS Drugs 20 11 2006 887 896
410. J.E. Tellew, and Z. Luo Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments Curr Top Med Chem 8 6 2008 506 520
411. E.P. Zorrilla, and G.F. Koob Progress in corticotropin-releasing factor-1 antagonist development Drug Discov Today 15 910 2010 371 383
412. H.E. Kunzel, A.W. Zobel, T. Nickel, N. Ackl, M. Uhr, and A. Sonntag Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects J Psychiatr Res 37 6 2003 525 533
413. L.K. Takahashi, M.M. Chan, and M.L. Pilar Predator odor fear conditioning: current perspectives and new directions Neurosci Biobehav Rev 32 7 2008 1218 1227
414. G.F. Koob, and F.E. Bloom Corticotropin-releasing factor and behavior Fed Proc 44 1 Pt 2 1985 259 263
415. A.J. Dunn, and C.W. Berridge Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15 2 1990 71 100
416. J.A. Carr Novel effects of CRF on visuomotor behavior and autonomic function in anuran amphibians Gen Comp Endocrinol 146 1 2006 28 35
417. C.A. Lowry, and F.L. Moore Regulation of behavioral responses by corticotropin-releasing factor Gen Comp Endocrinol 146 1 2006 19 27
418. R.E. Carpenter, and C.H. Summers Learning strategies during fear conditioning Neurobiol Learn Mem 91 4 2009 415 423
419. C.H. Summers, R.E. Carpenter, and D.H. Arendt A new model of fear learning Soc Neurosci Abstr 33 2007 529
420. R.E. Carpenter, B. Sabirzhanov, and C.H. Summers Molecular substrates of social fear conditioning in the hippocampus of rainbow trout Soc Neurosci Abstr 35 2009 478
421. M. Cammarota, L.R. Bevilaqua, M.R. Vianna, J.H. Medina, and I. Izquierdo The extinction of conditioned fear: structural and molecular basis and therapeutic use Rev Bras Psiquiatr 29 1 2007 80 85
422. L. Brodsky, A.L. Doerman, L.S. Palmer, G.F. Slade, and F.A. Munasifi Post traumatic stress disorder: an eclectic approach Int J Psychosom 37 14 1990 89 95
423. W.H. Cai, J. Blundell, J. Han, R.W. Greene, and C.M. Powell Postreactivation glucocorticoids impair recall of established fear memory J Neurosci 26 37 2006 9560 9566
424. P. Verhaert, S. Marivoet, F. Vandesande, and A. De Loof Localization of CRF immunoreactivity in the central nervous system of three vertebrate and one insect species Cell Tissue Res 238 1 1984 49 53
425. R. Taussig, and R.H. Scheller The Aplysia FMRFamide gene encodes sequences related to mammalian brain peptides DNA 5 6 1986 453 461
426. H. Suzuki, T. Muraoka, and T. Yamamoto Localization of corticotropin-releasing factor-immunoreactive nervous tissue and colocalization with neuropeptide Y-like substance in the optic lobe and peduncle complex of the octopus (Octopus vulgaris) Cell Tissue Res 313 1 2003 129 138
427. D.A. Lovejoy, and S. Jahan Phylogeny of the corticotropin-releasing factor family of peptides in the metazoa Gen Comp Endocrinol 146 1 2006 1 8
428. K. Owada, C. Yamada, and H. Kobayashi Immunohistochemical investigation of urotensins in the caudal spinal cord of four species of elasmobranchs and the lamprey, Lampetra japonica Cell Tissue Res 242 3 1985 527 530
429. K. Lederis, A. Letter, D. McMaster, T. Ichikawa, K.L. MacCannell, and Y. Kobayashi Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides Can J Biochem Cell Biol 61 7 1983 602 614
430. N.J. Bernier, S.L. Alderman, and E.N. Bristow Heads or tails? Stressor-specific expression of corticotropin-releasing factor and urotensin I in the preoptic area and caudal neurosecretory system of rainbow trout J Endocrinol 196 3 2008 637 648
431. L. Mola, A. Gambarelli, and A. Pederzoli Immunolocalization of corticotropin-releasing factor (CRF) and corticotropin-releasing factor receptor 2 (CRF-R2) in the developing gut of the sea bass (Dicentrarchus labrax L.) Acta Histochem 2009 (Epub ahead of print)
432. G. Gaudino, A. Fasolo, G. Merlo, L.H. Lazarus, T. Renda, and L. D'Este Active peptides from amphibian skin are also amphibian neuropeptides Peptides 6 Suppl. 3 1985 209 213
433. J.A. Carr, and D.O. Norris Immunohistochemical localization of corticotropin-releasing factor- and arginine vasotocin-like immunoreactivities in the brain and pituitary of the American bullfrog (Rana catesbeiana) during development and metamorphosis Gen Comp Endocrinol 78 2 1990 180 188
434. G.C. Boorse, and R.J. Denver Expression and hypophysiotropic actions of corticotropin-releasing factor in Xenopus laevis Gen Comp Endocrinol 137 3 2004 272 282
435. C.A. Lowry, J.D. Rose, and F.L. Moore Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian Horm Behav 30 1 1996 50 59
436. D.E. Williamson, and W.D. Eldred Synaptic organization of two types of amacrine cells with CRF-like immunoreactivity in the turtle retina Vis Neurosci 6 3 1991 257 269
437. C.B. Ganesh, and H.N. Yajurvedi Corticotropin-releasing factor antagonist attenuates stress-induced inhibition of seasonal ovarian recrudescence in the lizard Mabuya carinata Gen Comp Endocrinol 126 2 2002 144 152
438. R. Jozsa, S. Vigh, A.V. Schally, and B. Mess Localization of corticotropin-releasing factor-containing neurons in the brain of the domestic fowl. An immunohistochemical study Cell Tissue Res 236 1 1984 245 248
439. G.F. Ball, P.L. Faris, and J.C. Wingfield Immunohistochemical localization of corticotropin-releasing factor in selected brain areas of the European starling (Sturnus vulgaris) and the song sparrow (Melospiza melodia) Cell Tissue Res 257 1 1989 155 161
440. L.M. Romero, S.C. Dean, and J.C. Wingfield Neurally active stress peptide inhibits territorial defense in wild birds Horm Behav 34 3 1998 239 247
441. C. Bugnon, D. Fellmann, A. Gouget, J.L. Bresson, M.C. Clavequin, and M. Hadjiyiassemis Corticoliberin neurons: cytophysiology, phylogeny and ontogeny J Steroid Biochem 20 1 1984 183 195
442. D. Fellmann, C. Bugnon, J.L. Bresson, A. Gouget, J. Cardot, and M.C. Clavequin The CRF neuron: immunocytochemical study Peptides 5 Suppl 1 1984 19 33
443. G. Skofitsch, and D.M. Jacobowitz Distribution of corticotropin releasing factor-like immunoreactivity in the rat brain by immunohistochemistry and radioimmunoassay: comparison and characterization of ovine and rat/human CRF antisera Peptides 6 2 1985 319 336
444. D.P. Behan, O. Khongsaly, N. Ling, and E.B. De Souza Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free" CRF levels in human brain Brain Res 725 2 1996 263 267